An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert

Conditions

• Primary Open-Angle Glaucoma
• Ocular Hypertension

Interventions

• DRUG: Bimatoprost

Sponsor

ForSight Vision5, Inc.